s6y
Company name or ticker
Search
RECURSION PHARMACEUTICALS, INC.
4
Bumpus Namandje: Statement of changes in beneficial ownership of securities
Filed
Monday, June 22, 2026
Period
Jun 17, 2026
Accession number
0001601830-26-000082
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header